The small bowel, low-dose aspirin and PPIs—should we be concerned?
Crossref DOI link: https://doi.org/10.1038/nrgastro.2014.120
Published Online: 2014-07-08
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lanas, Angel
Sostres, Carlos
Text and Data Mining valid from 2014-07-08
Article History
First Online: 8 July 2014
Competing interests
: A.L. has received funding from Astra-Zeneca, Bayer and Pfizer. C.S. declares no competing interests.